康美药业
(600518)
| 流通市值：273.68亿 | | | 总市值：274.50亿 |
| 流通股本：138.22亿 | | | 总股本：138.64亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 894,142,348.78 | 977,841,602.98 | 773,508,915.68 | 794,968,788.99 |
| 应收票据及应收账款 | 2,469,459,156.97 | 2,376,089,517.42 | 2,313,965,965.38 | 2,234,675,989.02 |
| 其中：应收票据 | 54,036,384.93 | 44,124,091.52 | 58,610,619.91 | 60,213,930.17 |
| 应收账款 | 2,415,422,772.04 | 2,331,965,425.9 | 2,255,355,345.47 | 2,174,462,058.85 |
| 应收款项融资 | 44,936,346.01 | 14,654,666.96 | 26,285,582.31 | 26,816,947.45 |
| 预付款项 | 129,809,295.16 | 175,562,999.48 | 116,852,305.37 | 131,173,606.03 |
| 其他应收款合计 | 659,922,652.91 | 659,162,931.1 | 690,112,054.54 | 722,905,714.98 |
| 存货 | 2,512,355,484.3 | 2,510,410,246.96 | 2,885,879,627.37 | 2,886,652,286.86 |
| 其他流动资产 | 183,336,715.62 | 186,304,972.11 | 203,077,541.86 | 196,684,955.9 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 6,894,041,768.25 | 6,900,107,901.54 | 7,009,764,400.19 | 6,993,951,049.57 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 1,111,586.01 | 1,111,586.01 | 1,156,164.06 | 1,121,791.73 |
| 投资性房地产 | 2,718,493,893.82 | 2,740,868,666.98 | 2,707,598,535.8 | 2,757,817,060.84 |
| 固定资产 | 3,170,992,500.25 | 3,207,783,399.71 | 3,355,658,629.01 | 3,370,628,870.26 |
| 在建工程 | 176,255,667.23 | 175,324,324.81 | 172,773,268.61 | 172,641,370.06 |
| 生产性生物资产 | 375,218.18 | 379,405.93 | 658,453.75 | 679,622.32 |
| 使用权资产 | 106,155,484.14 | 116,059,971 | 182,153,238.22 | 193,568,851.32 |
| 无形资产 | 404,857,671.94 | 409,466,623.05 | 465,119,525.13 | 469,980,786.35 |
| 商誉 | 106,350,551.22 | 106,350,551.22 | 106,350,551.22 | 106,350,551.22 |
| 长期待摊费用 | 51,083,872.73 | 55,050,910.61 | 61,208,617.56 | 61,479,157.16 |
| 递延所得税资产 | 71,028,453.72 | 74,361,934.25 | 97,534,786.89 | 100,404,166.92 |
| 其他非流动资产 | 13,093,011.46 | 10,825,040.15 | 33,630,471.37 | 28,381,154.91 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 6,819,797,910.7 | 6,897,582,413.72 | 7,183,842,241.62 | 7,263,053,383.09 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 13,713,839,678.95 | 13,797,690,315.26 | 14,193,606,641.81 | 14,257,004,432.66 |
| 流动负债: | | | | |
| 短期借款 | 33,001,903.3 | 15,827,647.79 | 12,202,364.42 | 23,410,292.01 |
| 应付票据及应付账款 | 2,505,033,363.34 | 2,545,687,270.01 | 2,543,103,864.13 | 2,523,347,411.14 |
| 其中：应付票据 | 75,165,790.39 | 74,052,220.31 | 37,784,826.4 | 89,963,387.77 |
| 应付账款 | 2,429,867,572.95 | 2,471,635,049.7 | 2,505,319,037.73 | 2,433,384,023.37 |
| 预收款项 | 48,009,825.69 | 51,317,350.49 | 39,957,268.78 | 45,293,718.8 |
| 合同负债 | 140,222,907.67 | 118,816,866.15 | 172,840,915.39 | 151,909,962.74 |
| 应付职工薪酬 | 49,207,451.25 | 66,584,398.2 | 62,643,489.33 | 59,351,301.44 |
| 应交税费 | 414,988,734.23 | 418,038,334.28 | 410,537,678.66 | 405,331,817.25 |
| 其他应付款合计 | 1,327,930,346.23 | 1,338,449,354.59 | 1,548,104,538.88 | 1,372,422,806.77 |
| 应付股利 | 2,250,000 | 2,250,000 | 2,500,000 | - |
| 一年内到期的非流动负债 | 25,734,905.23 | 28,347,177.78 | 34,535,911.14 | 36,281,399.28 |
| 其他流动负债 | 1,273,928,152.07 | 1,310,499,391.64 | 86,592,203.16 | 84,758,811.86 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 5,818,057,589.01 | 5,893,567,790.93 | 4,910,518,233.89 | 4,702,107,521.29 |
| 非流动负债: | | | | |
| 租赁负债 | 87,914,858.32 | 94,951,726.97 | 169,194,273.14 | 176,455,875.14 |
| 长期应付款 | - | - | 780,893,989.54 | 805,122,692.05 |
| 预计负债 | 17,791,813.26 | 17,791,813.26 | 621,497,764.42 | 823,826,802.63 |
| 递延收益 | 547,638,995.5 | 555,779,253.03 | 591,848,499.35 | 603,416,654.48 |
| 递延所得税负债 | 24,707,828.29 | 26,849,311.85 | 43,853,546.01 | 46,433,814.93 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 678,053,495.37 | 695,372,105.11 | 2,207,288,072.46 | 2,455,255,839.23 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 6,496,111,084.38 | 6,588,939,896.04 | 7,117,806,306.35 | 7,157,363,360.52 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 13,863,866,690 | 13,863,866,690 | 13,863,866,690 | 13,863,866,690 |
| 资本公积 | 18,782,890,509.57 | 18,782,890,509.57 | 18,782,890,509.57 | 18,782,890,509.57 |
| 减:库存股 | 1,106,944,529.5 | 1,106,944,529.5 | 1,235,733,713.4 | 1,224,388,047.3 |
| 其他综合收益 | -264,338.17 | -264,338.17 | -218,191.98 | -251,969.2 |
| 专项储备 | 1,450,808.82 | 1,441,304.2 | 1,405,580.76 | 1,370,111.37 |
| 盈余公积 | 1,525,575,798.27 | 1,525,575,798.27 | 1,525,575,798.27 | 1,525,575,798.27 |
| 未分配利润 | -25,883,855,192.68 | -25,892,360,975.48 | -25,895,919,100.61 | -25,885,174,312.37 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 7,182,719,746.31 | 7,174,204,458.89 | 7,041,867,572.61 | 7,063,888,780.34 |
| 少数股东权益 | 35,008,848.26 | 34,545,960.33 | 33,932,762.85 | 35,752,291.8 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 7,217,728,594.57 | 7,208,750,419.22 | 7,075,800,335.46 | 7,099,641,072.14 |
| 负债和股东权益合计 | 13,713,839,678.95 | 13,797,690,315.26 | 14,193,606,641.81 | 14,257,004,432.66 |
| 公告日期 | 2025-04-30 | 2025-04-19 | 2024-10-31 | 2024-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |